Back to search

Article

Identification and targeting of a unique NaV1.7 domain driving chronic pain

2022-07-10

Abstract excerpt

Despite identification of several small molecules directly targeting the voltage-gated sodium channel NaV1.7, none has been clinically successful. We reported that preventing addition of a small ubiquitin-like modifier (SUMO) on the NaV1.7-interacting cytosolic collapsin response mediator protein 2 (CRMP2) blocked NaV1.7 functions and was antinociceptive in rodents. Here, we discovered a 15 amino acid CRMP2 regula...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
18f5726d-8147-5fe7-ba85-d66215e6e2ef
DOI
10.1101/2022.07.09.499431
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification and targeting of a unique NaV1.7 domain driving chronic painDOI 10.1101/2022.07.09.499431
Select a neighboring publication to make it the new centre.